These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24378999)

  • 61. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM
    Manag Care; 2000 Sep; 9(9 Suppl):2-6. PubMed ID: 11729417
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Changes of twenty-four-hour profile blood pressure and its correction of patients with arterial hypertension on the background of combined antihypertensive therapy application].
    Solomennchuk TM; Slaba NA; Prots'ko VV; Bedzaĭ AO
    Wiad Lek; 2014; 67(2 Pt 2):254-7. PubMed ID: 25796840
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.
    Lins R; Haerden Y; de Vries C
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):29-36. PubMed ID: 28058623
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Double blind randomized comparative study of two antihypertensive combinations. Enalapril-hydrochlorothiazide versus enalapril-nifedipine in 240 hypertensive patients resistant to monotherapy].
    Frances Y; Lafay V; Madona O; Chastang C; Souchet T; Chazelle F
    Therapie; 1996; 51(1):35-9. PubMed ID: 8762218
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB; Jarvis B
    Drugs; 2002; 62(5):787-816. PubMed ID: 11929332
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of aliskiren on vascular remodelling in small retinal circulation.
    Jumar A; Ott C; Kistner I; Friedrich S; Schmidt S; Harazny JM; Schmieder RE
    J Hypertens; 2015 Dec; 33(12):2491-9. PubMed ID: 26398851
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of lercanidipine on kidney microanatomy in Cohen-Rosenthal diabetic hypertensive rats.
    Rosenthal T; Rosenmann E; Tomassoni D; Amenta F
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):145-52. PubMed ID: 17562785
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR; Whelton PK;
    N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract]   [Full Text] [Related]  

  • 73. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
    Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
    Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Urano T; Takada Y; Takada A
    Am Heart J; 1999 Jun; 137(6):1094-9. PubMed ID: 10347337
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship of wall-to-lumen ratio of retinal arterioles with clinic and 24-hour blood pressure.
    Salvetti M; Agabiti Rosei C; Paini A; Aggiusti C; Cancarini A; Duse S; Semeraro F; Rizzoni D; Agabiti Rosei E; Muiesan ML
    Hypertension; 2014 May; 63(5):1110-5. PubMed ID: 24516107
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of a long-term treatment with aliskiren or ramipril on structural alterations of subcutaneous small-resistance arteries of diabetic hypertensive patients.
    De Ciuceis C; Savoia C; Arrabito E; Porteri E; Mazza M; Rossini C; Duse S; Semeraro F; Agabiti Rosei C; Alonzo A; Sada L; La Boria E; Sarkar A; Petroboni B; Mercantini P; Volpe M; Rizzoni D; Agabiti Rosei E
    Hypertension; 2014 Oct; 64(4):717-24. PubMed ID: 24980672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
    Chazova IE; Ratova LG; Dmitriev VV; Khanbalaeva MN; Kotkina TI
    Ter Arkh; 2003; 75(8):21-6. PubMed ID: 14520845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.